Form 4 for EFX Equifax
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0001225208-22-002197 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-11 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +8,978 | 58.3K | +18% | $0 |
| DM | 2022-02-15 | 2022-02-11 | EFX | Begor Mark W | CEO, Dir | A - Grant | $0.00 | +37.2K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | A | A | 8,978 | $0.00 | 58,302 | D | — | — | (F1) Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025. (F2) Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| 2 | Derivative | Stock Option/Right to Buy | 2022-02-11 | A | A | 19,649 | $0.00 | 19,649 | D | $247.50 · 2025-12-31 to 2029-02-11 | 19,649 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on December 31, 2025. |
| 3 | Derivative | Stock Option/Right to Buy | 2022-02-11 | A | A | 17,522 | $0.00 | 17,522 | D | $270.50 · 2025-12-31 to 2029-02-11 | 17,522 Common Stock | (F3) Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on December 31, 2025. |